Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density

Singapore Medical Journal

Volumn 53, Issue 12, 2012, Pages 808-813

  Arrabal Polo, Miguel Angel ^a   Arrabal Martin, Miguel ^a   Arias Santiago, Salvador ^b   Garrido Gomez, Juan ^a   de Haro Muñoz, Tomas ^a   Zuluaga Gomez, Armando ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Bone density; Calcium stones; Mineral metabolism; Osteopenia; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM OXALATE; CHLORIDE; CREATININE; OSTEOCALCIN; OXALIC ACID; PARATHYROID HORMONE; PHOSPHORUS; SODIUM; URIC ACID; WHEWELLITE;

ADULT; ARTICLE; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIURESIS; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; NEPHROLITHIASIS; OSTEOPENIA; OSTEOPOROSIS; URINALYSIS;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; BONE REMODELING; CALCIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCALCIURIA; INCIDENCE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NEPHROLITHIASIS; OSTEOPOROSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84871707478     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arrabal Martín M, Fernández Rodríguez A, Arrabal Polo MA, Ruíz García MJ, Zuluaga Gómez A. [Study of the physical-chemical factors in patients with renal lithiasis]. Arch Esp Urol 2006; 59:583-94. Spanish.
2. Lancina Martín JA, Rodríguez-Rivera García J, Novás Castro S, et al. [Metabolic risk factors in calcium urolithiasis according to gender and age of patients]. Actas Urol Esp 2002; 26:111-20. Spanish.
3. Yagisawa T, Hayashi T, Yoshida A, et al. Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender. Eur Urol 2000; 38:297-301.
4. Giannini S, Nobile M, Sartori L, et al. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 1998; 50:94-100.
5. Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW. Nephrolithiasisassociated bone disease: pathogenesis and treatment options. Kidney Int 2011; 79:393-403.
6. Sutton RA. Stones and bones: bone resorption and metabolism in stone formers. Curr Opin Urol 1998; 8:309-13.
7. Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 2011; 108:1903-8.
8. Pak CYC, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115:26-32.
9. Krepinsky J, Ingram AJ, Churchill DN. Metabolic investigation of recurrent nephrolithiasis: compliance with recommendations. Urology 2000; 56:915-20.
10. Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin North Am 2007; 34:323-34.
11. Thorleifsson G, Holm H, Edvardsson V, et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009; 41:926-30.
12. Milliner DS. Stones, bones and heredity. Acta Paediatr Suppl 2006; 95:27-30.
13. Arrabal-Polo MA, Arrabal-Martin M, de Haro-Muñoz T, et al. Biochemical determinants of severe lithogenic activity in patients with idiopatic calcium nephrolithiasis. Urology 2012; 79:48-54.
14. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843, Genevea, Switzerland, 1994.
15. Chandhoke PS. Evaluation of the recurrent stone former. Urol Clin North Am 2007; 34:315-22.
16. Spivacow FR, Negri AL, del Valle EE, Calviño I, Zanchetta JR. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 2010; 42:471-5.
17. Amaro CR, Goldberg J, Amaro JL, Padovani CR. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005; 31:29-33.
18. del Valle E, Spivacow R, Zanchetta JR. [Metabolic changes in 2612 patients with nephrolithiasis]. Medicina (B Aires) 1999; 59:417-22. Spanish.
19. Spivacow FR, Negri AL, del Valle EE, et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23:1129-33.
20. Peres LA, Molina AS, Galles MH. Metabolic investigation of patients with urolithiasis in a specific region. Int Braz J Urol 2003; 29:217-20.
21. Audran M, Bataille P, Sebert JL, et al. [Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X-ray computed tomography and histomorphometry]. Rev Rhum Mal Osteoartic 1991; 58:747-50.
22. Zanchetta JR, Rodriguez G, Negri AL, del Valle E, Spivacow FR. Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 1996; 73:557-60.
23. Jaeger P, Lippuner K, Casez JP, et al. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994; 9:1525-32.
24. Srivastava T, Winston MJ, Auron A, Alon US. Urine calcium/citrate ratio in children with hypercalciuric stones. Pediatr Res 2009; 66:85-90.
25. DeFoor WR, Jackson E, Minevich E, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology 2010; 76:242-5.
26. Pak CY, Peterson RD, Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol 2002; 168:31-4.
27. Caudarella R, Vescini F, Buffa A, Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front Biosci 2003; 8:s1084-106.